HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yawei Yuan Selected Research

Squamous Cell Carcinoma of Head and Neck

11/2020Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
3/2020A key genomic signature associated with lymphovascular invasion in head and neck squamous cell carcinoma.
1/2018Efficacy and safety of anti-EGFR agents administered concurrently with standard therapies for patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis of randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yawei Yuan Research Topics

Disease

28Neoplasms (Cancer)
01/2022 - 10/2003
11Nasopharyngeal Carcinoma
03/2022 - 10/2013
8Breast Neoplasms (Breast Cancer)
01/2021 - 04/2012
7Neoplasm Metastasis (Metastasis)
03/2022 - 02/2015
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 12/2017
4Brain Neoplasms (Brain Tumor)
01/2020 - 07/2017
4Lung Neoplasms (Lung Cancer)
01/2020 - 07/2012
3Glioma (Gliomas)
01/2022 - 11/2016
3Carcinogenesis
10/2021 - 11/2016
3Carcinoma (Carcinomatosis)
01/2021 - 10/2003
3Squamous Cell Carcinoma of Head and Neck
11/2020 - 01/2018
3Hypoxia (Hypoxemia)
12/2018 - 07/2015
2Cognitive Dysfunction
06/2022 - 01/2022
2Inflammation (Inflammations)
06/2022 - 10/2020
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2018
2Esophageal Squamous Cell Carcinoma
03/2020 - 01/2019
2Stomach Neoplasms (Stomach Cancer)
05/2019 - 01/2013
1Disease Progression
03/2022
1Adenocarcinoma
01/2021
1COVID-19
01/2021
1Neuroendocrine Carcinoma
01/2021
1Urologic Neoplasms (Urological Cancer)
01/2021
1Fibrosis (Cirrhosis)
01/2019
1Pneumonia (Pneumonitis)
01/2019
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2019
1Glioblastoma (Glioblastoma Multiforme)
12/2018

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2003
6Messenger RNA (mRNA)IBA
01/2022 - 03/2012
6Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2003
5Small Interfering RNA (siRNA)IBA
12/2021 - 01/2016
5MicroRNAs (MicroRNA)IBA
01/2021 - 07/2012
3Pharmaceutical PreparationsIBA
01/2022 - 01/2021
3Biological ProductsIBA
01/2022 - 10/2003
3CytokinesIBA
11/2020 - 04/2012
2IsofluraneFDA LinkGeneric
06/2022 - 01/2022
2Indicators and Reagents (Reagents)IBA
03/2022 - 01/2022
2Anaplastic Lymphoma KinaseIBA
01/2022 - 08/2015
2VimentinIBA
01/2021 - 08/2015
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2021 - 01/2017
2RNA (Ribonucleic Acid)IBA
01/2021 - 11/2020
2NucleotidesIBA
01/2021 - 11/2020
2AngiotensinogenIBA
01/2021 - 12/2018
2Long Noncoding RNAIBA
10/2019 - 11/2016
2Angiotensin IIIBA
12/2018 - 01/2017
2Lactic Acid (Lactate)FDA LinkGeneric
12/2018 - 01/2017
2Chymases (Chymase)IBA
12/2018 - 01/2017
2ErbB Receptors (EGF Receptor)IBA
08/2018 - 01/2018
1Superoxide DismutaseIBA
03/2022
1PhosphoproteinsIBA
01/2022
1apatinibIBA
12/2021
1cyclic arginine-glycine-aspartic acid peptideIBA
12/2021
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2021
1Hormones (Hormone)IBA
10/2021
1MelatoninIBA
10/2021
1Capsules (Microcapsules)IBA
09/2021
1SynaptophysinIBA
01/2021
1GSK 461364IBA
01/2021
1Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2021
13-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA
01/2021
1TOR Serine-Threonine KinasesIBA
01/2021
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2021
1Serine Proteases (Serine Protease)IBA
01/2021
1Carcinoembryonic AntigenIBA
01/2021
1Chromogranin AIBA
01/2021
1Polo-Like Kinase 1IBA
01/2021
1histidine-rich proteinsIBA
01/2021
1Angiotensin-Converting Enzyme 2IBA
01/2021
1Lysine (L-Lysine)FDA Link
01/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1Mitogen-Activated Protein KinasesIBA
10/2020
1NF-kappa B (NF-kB)IBA
10/2020
1benzamidineIBA
03/2020
1alvocidib (flavopiridol)IBA
03/2020
1ZincIBA
03/2020
14- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA
03/2020
1Glutamine (L-Glutamine)FDA Link
03/2020
1nelarabine (506U78)FDA Link
03/2020
11- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)ureaIBA
03/2020
1Fluorouracil (Carac)FDA LinkGeneric
03/2020
1taxaneIBA
03/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1Ubiquitin-Specific ProteasesIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2019
1SincalideFDA Link
01/2019
1Small Cytoplasmic RNAIBA
01/2019
1N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA
01/2019
1PolygelineIBA
12/2018
1Immune Checkpoint InhibitorsIBA
08/2018

Therapy/Procedure

16Radiotherapy
01/2021 - 10/2013
9Therapeutics
04/2022 - 11/2016
5Drug Therapy (Chemotherapy)
01/2020 - 04/2014
4Chemoradiotherapy
01/2022 - 02/2015
2Immunotherapy
11/2020 - 12/2018
2Gastrectomy
05/2019 - 01/2013
1Anesthesia
06/2022
1Aftercare (After-Treatment)
01/2021
1Surgical Instruments (Clip)
01/2021
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2020